Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1007

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 3
Chunk 1007
---
 
     -  
     - 
  
    Forfeited 
     -  
     - 
  
    Unvested balance, December 31, 2024 
     -  
    $- 

The following table summarizes the Company’s
RSU activity for the year ended December 31, 2023:

    Number of
    Units  
    Weighted
    Average
    Grant 
    Date Fair
    Value 
  
    Unvested balance, December 31, 2022 
     -  
    $     - 
  
    Granted 
     4,270  
     52.20 
  
    Vested 
     (4,270) 
     52.20 
  
    Forfeited 
     -  
     - 
  
    Unvested balance, December 31, 2023 
     -  
    $- 

The Company recognized $0 of compensation expense
related to vested RSUs for the year ended December 31, 2024 ($222,480 for the year ended December 31, 2023). During the year ended December
31, 2024, 0 shares of common stock underlying RSUs vested (4,270 during the year ended December 31, 2023). During the year ended December
31, 2024, the Company issued 4,270 shares of common stock pursuant to RSUs which were fully vested as of December 31, 2023. At December
31, 2024, the Company had no unrecognized compensation cost related to unvested RSUs.

F-33

Annual Performance Bonus

In December 2024, the Board approved the payment
of 2024 performance bonuses to executives of the Company. Each executive was provided the option of receiving up to $20,000 in cash,
with the remainder paid in shares of common stock determined based on the closing market price on January 2, 2025. All shares issued
are eligible for net settlement up to the maximum allowable amount according to the IRS of 22%. As the number of shares is variable,
the Company determined this represents a liability for the fixed monetary amount that will be settled in shares. As of December 31, 2024,
the share-based liability amounted to $121,544, which is presented as a component of Accounts Payable and Accrued Expenses on the accompanying
Consolidated Balance